A dietitian breaks down who should use ashwagandha, possible side effects, and how to choose it safely for better results.

LINKER-MM4 trial shows linvoseltamab monotherapy achieves a 79% overall response rate in newly diagnosed MM patients, with 92 ...

A higher dose of the antibiotic rifampicin does not improve survival rates for patients with tuberculous meningitis. This ...

Extended-release buprenorphine is approved as a once-monthly subcutaneous injection for the treatment of moderate-to-severe ...

Learn more about what to expect if you’ve been prescribed this weight loss medication to help treat this chronic liver condition.

People aged 80 and older with a common type of lymphoma can take a half-dose of chemotherapy and be cured or significantly extend their survivorship with fewer toxic side effects, a new study shows.

The CDC has officially updated its immunization schedule to reflect its Advisory Committee on Immunization Practices’ ...

The CDC said it is still reviewing a separate ACIP recommendation related to doses administered after the birth-dose period.

U.S. health agencies led by Health and Human Services Secretary Robert F. Kennedy Jr., were beset by multiple controversies ...

This review synthesizes evidence that gut microbiota dysbiosis contributes to insulin resistance and symptom severity in ...

The U.S. Food and Drug Administration (FDA) has approved Enhertu (fam-trastuzumab deruxtecan-nxki) in combination with ...

The firm will share updated data and new analyses from its Phase III trial with the agency, which issued a complete response ...